Tar spot complex (TSC) is one of the most destructive foliar diseases of maize ( L.) in tropical and subtropical areas of Central and South America, causing significant grain yield losses when weather conditions are conducive. To dissect the genetic architecture of TSC resistance in maize, association mapping, in conjunction with linkage mapping, was conducted on an association-mapping panel and three biparental doubled-haploid (DH) populations using genotyping-by-sequencing (GBS) single-nucleotide polymorphisms (SNPs). Association mapping revealed four quantitative trait loci (QTL) on chromosome 2, 3, 7, and 8. All the QTL, except for the one on chromosome 3, were further validated by linkage mapping in different genetic backgrounds. Additional QTL were identified by linkage mapping alone. A major QTL located on bin 8.03 was consistently detected with the largest phenotypic explained variation: 13% in association-mapping analysis and 13.18 to 43.31% in linkage-mapping analysis. These results indicated that TSC resistance in maize was controlled by a major QTL located on bin 8.03 and several minor QTL with smaller effects on other chromosomes. Genomic prediction results showed moderate-to-high prediction accuracies in different populations using various training population sizes and marker densities. Prediction accuracy of TSC resistance was >0.50 when half of the population was included into the training set and 500 to 1,000 SNPs were used for prediction. Information obtained from this study can be used for developing functional molecular markers for marker-assisted selection (MAS) and for implementing genomic selection (GS) to improve TSC resistance in tropical maize.

Download full-text PDF

Source
http://dx.doi.org/10.3835/plantgenome2016.10.0099DOI Listing

Publication Analysis

Top Keywords

tsc resistance
16
resistance maize
12
linkage mapping
12
tar spot
8
spot complex
8
association mapping
8
qtl chromosome
8
major qtl
8
qtl located
8
located bin
8

Similar Publications

Background: Options for 'treatment-resistant bipolar depression' (TRBD) are limited. Two small, short-term, trials of pramipexole suggest it might be an option.

Aims: To evaluate the clinical effectiveness and safety of pramipexole in the management of TRBD.

View Article and Find Full Text PDF

Background Hemimegalencephaly (HME) is a rare congenital disorder that is initiated during embryonic development with abnormal growth of one hemisphere. Tuberous sclerosis complex (TSC), a genetic disorder, is rarely associated with HME. Methods We present a case of a newborn with HME with a confirmed mutation in the TSC-1 gene and describe the clinical course, findings on (amplitude integrated) electroencephalography (aEEG), cranial ultrasound (CUS), MRI, and the postmortem evaluation.

View Article and Find Full Text PDF

Tuberous sclerosis complex (TSC) is a rare genetic disorder characterized by the formation of benign tumors in various organs, particularly in the central nervous system. We aimed to delineate the molecular profile of Turkish individuals diagnosed with TSC by analyzing the TSC1 and TSC2 genes using next-generation sequencing (NGS). Sophia Genetics' Sophia Inherited Disease Panel was used to perform NGS on 22 individuals diagnosed with TSC and to identify pathogenic variants in the TSC1 and TSC2 genes.

View Article and Find Full Text PDF

The research necessity stems from the need to understand and evaluate the performance of Two-Stage Concrete (TSC) under triaxial compression conditions, as prior studies have predominantly focused on uniaxial and biaxial testing of conventional concrete (CC). This study represents the first comprehensive investigation into the triaxial compressive strength and related mechanical properties of TSC, addressing a critical gap in the existing body of literature. Three different mixtures were prepared, including one CC and two TSC variants with varying cement content.

View Article and Find Full Text PDF
Article Synopsis
  • - CBD is emerging as a beneficial treatment for children with drug-resistant epilepsy (DRE), particularly for conditions like Dravet syndrome, Lennox Gastaut syndrome, and Tuberous sclerosis complex, with regulatory approval in multiple countries.
  • - Clinical trials indicate that CBD can reduce seizure frequency and improve the quality of life for affected children, with a generally favorable safety profile, though minor side effects like sleepiness and diarrhea may occur.
  • - Accessibility and cost remain significant issues, especially in lower-income regions such as India, prompting a discussion on the opportunities and hurdles of integrating CBD into clinical practice while navigating the evolving regulatory environment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!